SAC Capital Advisors’s Johnson & Johnson JNJ Stock Holding History

SAC Capital Advisors’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-9,821	Closed	-$965K	–	527
2014 Q1	$965K	Sell	9,821 -214,992	-96%	-$19.9M	0.01%	965
2013 Q4	$20.6M	Buy	224,813 +73,690	+49%	+$6.79M	0.12%	205
2013 Q3	$13.1M	Buy	151,123 +129,892	+612%	+$11.7M	0.07%	311
2013 Q2	$1.82M	Buy	+21,231	New	+$1.8M	0.01%	781

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

SAC Capital Advisors's JNJ Position: Q2 2014 in Review

SAC Capital Advisors sold out of Johnson & Johnson (JNJ) in Q2 2014, closing a stake of 9,821 shares — an estimated $965K sold.

SAC Capital Advisors first reported a position in JNJ in Q2 2013 and held it in 4 quarters. The position peaked at $20.6M in Q4 2013. 1,975 funds tracked by Wall St. Rank hold JNJ as of Q2 2014.

SAC Capital Advisors reported no remaining Johnson & Johnson position as of Q2 2014 after selling out during the quarter.
SAC Capital Advisors sold 9,821 Johnson & Johnson shares in Q2 2014, an estimated $965K.
SAC Capital Advisors first reported a position in Johnson & Johnson in Q2 2013 and held it in 4 quarters.
SAC Capital Advisors's Johnson & Johnson position peaked at $20.6M in Q4 2013.
1,975 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2014.

Based on SAC Capital Advisors's 13F filing for Q2 2014.